Trials / Completed
CompletedNCT00812318
Healthy Volunteer Study To Assess The Bioavailability of GSK1265744 When Administered Orally Either When Fasted or Following a Meal.
A Single Dose, Randomized Study to Assess the Relative Bioavailability of Two Formulations and Food Effect on GSK1265744 in Healthy Male and Female Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- ViiV Healthcare · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the single dose relative bioavailability of GSK1265744 10mg administered in either oral solution fasted, two 5mg tablets fasted, or two 5mg tablets following a moderate meal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GSK1265744 10 mg oral solution | GSK1265744 |
| DRUG | GSK1265744 5 mg tablet | GSK1265744 5mg tablet, fasted |
| DRUG | GSK1265744 5 mg tablet | GSK1265744 5mg tablet, fed |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2008-12-22
- Last updated
- 2012-04-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00812318. Inclusion in this directory is not an endorsement.